Edward M Gillis sold $6,514 of BCDA
Senior Vice President, Devices at BioCardia, Inc.. 3,257 shares at an average of $2.00, traded Dec 20, 2024, filed Dec 26, 2024.
Score components
- +15RoleOfficer
- 0Trade size$7k at market
- +10Share of holdings soldSold 27% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.6%, 3m +15.5%, 6m -3.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-24-038363, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 20, 2024 | SOpen-market sale Common Stock | -3,257 | $2.00 | $6,514 | 8,968 | Dec 26, 2024 |
Related signals
Other insiders at BioCardia, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $1,030 1,000 shares | +0% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $1,995 1,900 shares | +0% | |
| 28Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $872 800 shares | +0% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $5,022 5,400 shares | +1% | |
| 28Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $1,748 1,900 shares | +1% | |
| 43Moderate | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $3,900 5,000 shares | +1% | |
| 38Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $415 500 shares | +0% | |
| 43Moderate | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $3,754 4,300 shares | +1% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $7,175 7,500 shares | +2% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $5,208 5,400 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.